Back to mobile site

Goldman Sachs Starts Ideaya Biosciences (IDYA) at Buy, Sees 46% Upside

May 24, 2023 4:06 AM EDT Send to a Friend
(Updated - May 24, 2023 6:34 AM EDT)

Goldman Sachs analyst Corinne Jenkins initiates coverage on Ideaya Biosciences (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login